99 related articles for article (PubMed ID: 36263020)
1. The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma.
Parkinson LM; Gillen SL; Woods LM; Chaytor L; Marcos D; Ali FR; Carroll JS; Philpott A
Front Cell Dev Biol; 2022; 10():942579. PubMed ID: 36263020
[TBL] [Abstract][Full Text] [Related]
2. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
3. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
4. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma.
Perri P; Ponzoni M; Corrias MV; Ceccherini I; Candiani S; Bachetti T
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771690
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells.
Gomez RL; Woods LM; Ramachandran R; Abou Tayoun AN; Philpott A; Ali FR
Front Cell Dev Biol; 2022; 10():943924. PubMed ID: 36147741
[TBL] [Abstract][Full Text] [Related]
6. ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity.
Abashkin DA; Karpov DS; Kurishev AO; Marilovtseva EV; Golimbet VE
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958729
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor is a tumor promoter in
Chaudhry KA; Jacobi JJ; Gillard BM; Karasik E; Martin JC; da Silva Fernandes T; Hurley E; Feltri ML; Attwood KM; Twist CJ; Smiraglia DJ; Long MD; Bianchi-Smiraglia A
iScience; 2023 Nov; 26(11):108303. PubMed ID: 38026169
[TBL] [Abstract][Full Text] [Related]
8. MYCN driven oncogenesis involves cooperation with WDR5 to activate canonical MYC targets and G9a to repress differentiation genes.
Liu Z; Zhang X; Xu M; Hong JJ; Ciardiello A; Lei H; Shern JF; Thiele CJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37781575
[TBL] [Abstract][Full Text] [Related]
9. Multi-site phospho-regulation of proneural transcription factors controls proliferation versus differentiation in development and reprogramming.
Philpott A
Neurogenesis (Austin); 2015; 2(1):e1049733. PubMed ID: 27502783
[TBL] [Abstract][Full Text] [Related]
10. Differentiated neuroblastoma cells remain epigenetically poised for de-differentiation to an immature state.
Guyer RA; Picard N; Mueller JL; Ohishi K; Leavitt A; Murphy AJ; Cornejo KM; Hotta R; Goldstein AM
Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 38095019
[TBL] [Abstract][Full Text] [Related]
11. WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines.
Bumpous LA; Moe KC; Wang J; Carver LA; Williams AG; Romer AS; Scobee JD; Maxwell JN; Jones CA; Chung DH; Tansey WP; Liu Q; Weissmiller AM
Oncogenesis; 2023 Jun; 12(1):32. PubMed ID: 37336886
[TBL] [Abstract][Full Text] [Related]
12. ASCL1 promotes Scrt2 expression in the neural tube.
Goes CP; Botezelli VS; De La Cruz SM; Cruz MC; Azambuja AP; Simoes-Costa M; Yan CYI
Front Cell Dev Biol; 2024; 12():1324584. PubMed ID: 38655067
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment.
Koeniger A; Polo P; Brichkina A; Finkernagel F; Visekruna A; Nist A; Stiewe T; Daude M; Diederich WE; Gress TM; Adhikary T; Lauth M
NAR Cancer; 2023 Mar; 5(1):zcad007. PubMed ID: 36755960
[TBL] [Abstract][Full Text] [Related]
14. MYC in Regulating Immunity: Metabolism and Beyond.
Gnanaprakasam JN; Wang R
Genes (Basel); 2017 Feb; 8(3):. PubMed ID: 28245597
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Enhanced proliferation of oligodendrocyte progenitor cells following retrovirus mediated Achaete-scute complex-like 1 overexpression in the postnatal cerebral cortex
Galante C; Marichal N; Scarante FF; Ghayad LM; Shi Y; Schuurmans C; Berninger B; Péron S
Front Neurosci; 2023; 17():1198640. PubMed ID: 37168927
[TBL] [Abstract][Full Text] [Related]
16. Genetic Predisposition to Neuroblastoma Results from a Regulatory Polymorphism that Promotes the Adrenergic Cell State.
Weichert-Leahey N; Shi H; Tao T; Oldridge DA; Durbin AD; Abraham BJ; Zimmerman MW; Zhu S; Wood AC; Reyon D; Joung JK; Young RA; Diskin SJ; Maris JM; Look AT
bioRxiv; 2023 Mar; ():. PubMed ID: 36909587
[TBL] [Abstract][Full Text] [Related]
17. Control Analysis of Protein-Protein Interaction Network Reveals Potential Regulatory Targets for MYCN.
Pan C; Zhu Y; Yu M; Zhao Y; Zhang C; Zhang X; Yao Y
Front Oncol; 2021; 11():633579. PubMed ID: 33968733
[TBL] [Abstract][Full Text] [Related]
18. ASCL1 and ASCL2 Define Distinct States of Neuroendocrine Prostate Cancer.
Cancer Discov; 2023 Dec; ():OF1. PubMed ID: 38064349
[TBL] [Abstract][Full Text] [Related]
19. A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons.
Kulatunga DCM; Ranaraja U; Kim EY; Kim RE; Kim DE; Ji KB; Kim MK
Sci Rep; 2024 May; 14(1):12113. PubMed ID: 38802572
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer.
Li Y; Yang X; Geng C; Liu Y; Tang T; Zhang L; Liu F; Zhang M; Hao J; Ma L
Front Immunol; 2024; 15():1390261. PubMed ID: 38726001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
